CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 324.2

Change

-3.15 (-0.96)%

Market Cap

USD 0.10B

Volume

2.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-1.79 (-4.06%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-29.10 (-5.59%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-20.31 (-5.44%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-1.64 (-4.84%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-6.61 (-2.62%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-25.15 (-5.72%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-17.61 (-5.24%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-2.94 (-5.60%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.24 (-3.40%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-6.00 (-7.15%)

USD 5.54B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.44% 97% N/A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.44% 97% N/A 87% B+
Trailing 12 Months  
Capital Gain 23.60% 95% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.60% 95% A 89% A-
Trailing 5 Years  
Capital Gain 132.60% 90% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 132.60% 90% A- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 15.96% 83% B 80% B-
Dividend Return 15.96% 78% C+ 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.94% 52% F 39% F
Risk Adjusted Return 123.38% 93% A 48% F
Market Capitalization 0.10B 28% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.